Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA; ATLANTIS trialists. Ford AC, et al. Among authors: howdon d. Lancet. 2023 Nov 11;402(10414):1773-1785. doi: 10.1016/S0140-6736(23)01523-4. Epub 2023 Oct 16. Lancet. 2023. PMID: 37858323 Free article. Clinical Trial.
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.
Alderson SL, Wright-Hughes A, Ford AC, Farrin A, Hartley S, Fernandez C, Taylor C, Ow PL, Teasdale E, Howdon D, Guthrie E, Foy R, Ridd MJ, Bishop FL, Muir D, Chaddock M, Herbert A, Cooper D, Gibbins R, Newman S, Cook H, Longo R, Everitt H. Alderson SL, et al. Among authors: howdon d. Trials. 2022 Jul 8;23(1):552. doi: 10.1186/s13063-022-06492-6. Trials. 2022. PMID: 35804433 Free PMC article.
Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.
Green SMC, French DP, Graham CD, Hall LH, Rousseau N, Foy R, Clark J, Parbutt C, Raine E, Gardner B, Velikova G, Moore SJL, Buxton J; ROSETA investigators; Smith SG. Green SMC, et al. BMC Health Serv Res. 2022 Aug 24;22(1):1081. doi: 10.1186/s12913-022-08243-4. BMC Health Serv Res. 2022. PMID: 36002831 Free PMC article.
Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial.
Smith SG, Green SMC, Ellison R, Foy R, Graham CD, Mason E, French DP, Hall LH, Wilkes H, McNaught E, Raine E, Walwyn R, Howdon D, Clark J, Rousseau N, Buxton J, Moore SJL, Parbutt C, Velikova G, Farrin A, Collinson M. Smith SG, et al. Among authors: howdon d. BMJ Open. 2023 Feb 3;13(2):e069971. doi: 10.1136/bmjopen-2022-069971. BMJ Open. 2023. PMID: 36737093 Free PMC article.
Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial.
Green SMC, Hall LH, Rousseau N, French DP, Graham CD, Collinson M, Mason E, Wilkes H, Howdon D, Foy R, Walwyn R, Clark J, Parbutt C, Raine E, Ellison R, Buxton J, Moore SJL, Velikova G, Farrin A, Smith SG. Green SMC, et al. Among authors: howdon d. NIHR Open Res. 2023 Apr 24;3:3. doi: 10.3310/nihropenres.13337.2. eCollection 2023. NIHR Open Res. 2023. PMID: 37881449 Free PMC article.
31 results